This compound is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of active pharmaceutical ingredients (APIs). Its structure, featuring a trifluoromethoxy group, is particularly valuable in the development of drugs targeting the central nervous system (CNS), such as antidepressants, antipsychotics, and anxiolytics. The chiral nature of the molecule allows for the creation of enantiomerically pure compounds, which is crucial for enhancing drug efficacy and reducing side effects. Additionally, it is employed in research and development for studying receptor interactions and designing novel therapeutic agents with improved selectivity and potency.